PBS gets set for an update 2024 Innovative Medicines Special Report The Pharmaceutical Benefits Scheme, touted as one the world’s best, has been around for 76 years. How well is it ageing?
Resistance movement: The war against microbe evolution April 2, 2024 By Simon Webster 2024 Innovative Medicines Special Report Antimicrobial resistance poses a great threat partly because microbes are evolving faster than humans are developing new drugs to kill them.
Regulators must move faster to put innovative medicines into patients’ hands April 2, 2024 By Joshua Gliddon 2024 Innovative Medicines Special Report While the Therapeutic Goods Administration works quickly to review new medicines, the funding process post-review needs streamlining.
How the latest medicines get into the remotest communities April 2, 2024 By Christopher Niesche 2024 Innovative Medicines Special Report The Community Service Obligation ensures equal access to Pharmaceutical Benefits Scheme medicines to all Australians.
Australian specialists want top five OECD ranking for medicines access April 2, 2024 By Lisa Julian 2024 Innovative Medicines Special Report Australia is currently 16th among OECD countries, and medical specialists are keen to see a rise through the ranks.
Battle for the best Health Technology Assessment processes April 2, 2024 By Tom Ravlic 2024 Innovative Medicines Special Report There’s been pushback to a paper proposing changes to the system that decides which health technologies receive government funding.
Why medicines access requires a social perspective April 2, 2024 By Joshua Gliddon 2024 Innovative Medicines Special Report Australia lags behind other nations when it comes to access to new life-saving and innovative medical treatments.
Robodebt probe to grind on, update reveals no APS sackings February 8, 2024 By Julian Bajkowski Community & Social Out of 16 people referred to robodebt investigators, one has been let off and just four cases have progressed to ‘preliminary determination’.
Premium Insights and analysis Big name, no consequences: Justice for robodebt heist ebbs away November 14, 2023 By Julian Bajkowski Career Advice There’s now a real question as to whether the APS can heal itself to avoid past errors. Ain’t no sunshine. Ain’t no closure.
Public servants set to escape sackings over robodebt November 13, 2023 By Julian Bajkowski Community & Social Justice delayed is justice denied. Now the APSC is facing questions of the efficacy of its sanctions and Shorten flags more litigation.
First robodebt royal commission scalp confirmed at PwC July 7, 2023 By Julian Bajkowski and Tom Ravlic Community & Social Acting PwC Australia boss confirms a partner who worked with the Department of Human Services had parted ways with the firm.
Premium Case studies Transformers vs Care Bears: How an APS culture war produced the monster of robodebt July 7, 2023 By Julian Bajkowski Community & Social The seeds of robodebt were planted a decade before it spawned. Forcing public servants to pick sides was the bitter harvest.
Government moves to help some older Australians with climbing energy bills May 30, 2023 By Melissa Coade Community & Social Up to $500 will be given to people with a Commonwealth Seniors Health Card (CSHC) to ease the impact of electricity prices for older people.
Dodgy pharmacist sentenced after fraud tip-off to health hotline June 20, 2022 By Melissa Coade Federal A former pharmacist found guilty of rorting the Pharmaceutical Benefits Scheme with false claims worth millions will spend at least four years in prison.
Election 2022: Coalition outlines health policy, focuses on rural services May 4, 2022 By Tom Ravlic Federal The Coalition has promised $146 million to address the shortage of doctors and other medical professionals in rural and regional communities.